Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
ProBioGen Launches AGE1.CR.ReX Designer Cell Line for High-Titer Poxvirus Production
Wednesday, May 27, 2026ProBioGen today announced the launch of AGECRReX its nextgeneration avian designer cell line for stable hightiter poxvirus production and rapid generation of recombinant modified vaccinia Ankara MVA
Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine
Tuesday, May 26, 2026H Lundbeck AS Lundbeck today announced that the Ministry of Food and Drug Safety MFDS of South Korea has granted marketing authorization for eptinezumab for use in adults with migraine
Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery
Thursday, May 21, 2026Incyte and Genesis Molecular AI today announced a significant expansion of their strategic collaboration building and deploying stateoftheart AI to accelerate the discovery of novel molecules for collaboration targets selected by Incyte
Hansa Biopharma enters into €115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA
Tuesday, May 19, 2026Hansa Biopharma AB and SERB SA SERB today announced an exclusive licensing agreement for development and commercialization of IDEFIRIX imlifidase in the European Union EU United Kingdom UK
Parexel Launches ParexelAI™, Delivering AI Innovation to Accelerate Clinical Development
Tuesday, May 19, 2026Parexel a leading global clinical development partner providing insightsdriven Clinical and Consulting solutions to the worlds life sciences industry today introduced ParexelAI an innovative proprietary suite of humanled AI services
Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery
Tuesday, May 19, 2026Sino Biological Inc a global leader in recombinant technology is proud to announce the launch of its innovative XPressMAX CellFree Protein Synthesis Kit Cat CFKIT a cuttingedge solution designed
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
Monday, May 18, 2026Boehringer Ingelheim today announced that Japans Ministry of Health Labour and Welfare MHLW has approved JASCAYD nerandomilast for the treatment of adults with idiopathic pulmonary fibrosis IPF
IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities
Friday, May 15, 2026IQVIA a leading global provider of clinical research services commercial insights and healthcare intelligence to the life sciences and healthcare industries is advancing its strategic collaboration with Kexing Biopharm
Vetter Starts Construction of a New Production Site in Germany
Thursday, May 14, 2026Vetter a leading Contract Development and Manufacturing Organization CDMO is celebrating the start of construction on its new site in Saarlouis with a traditional groundbreaking ceremony today
Nuclera Launches Antibody Triage Service to Advance AI-Driven Antibody Discovery
Tuesday, May 12, 2026Nuclera the biotechnology company enabling rapid access to highquality proteins today announced the launch of its antibody screening service to streamline the transition from antibody hit generation to lead selection
